Merit Medical Systems, Inc. (MMSI)

In the past six months, Merit Medical Systems exceeded Q3 2025 forecasts, reporting earnings per share of $0.92 and revenue of $384.2 million, leading to a 2.09% after-hours stock increase. Revenue growth for Q3 2025 was 13% year-over-year, with strong performance in both U.S. and international markets. Martha Aronson was appointed as President and Chief Executive Officer in October 2025. Over the past year, MMSI's stock price has decreased by 24.40%, and within the last 90 days, the stock has also experienced one analyst downgrade.

Merit Medical Systems' demand for its products and services appears to be stable rather than seasonal. The company's annualized revenue growth aligns with its five-year trend, suggesting consistent demand due to the recurring need for its medical devices and growing global demand for advanced treatments.

Merit Medical Systems, Inc. is a global manufacturer and marketer of medical devices used in diagnostic and interventional procedures, operating in the Healthcare sector, specifically in the Medical Instruments & Supplies and Medical Devices & Instruments industries. The company's product portfolio is segmented into Cardiovascular and Endoscopy, serving physicians and hospitals in critical care settings and supporting minimally invasive treatment options across various specialties.

Merit Medical Systems is headquartered in South Jordan, Utah, and maintains a significant global presence with manufacturing and distribution facilities across North America, Europe, and Asia. Its products are sold in over 90 countries worldwide, supported by regional sales offices and distribution centers in multiple regions.

Merit Medical Systems generally holds a positive brand reputation, with a consensus rating of "Moderate Buy" from analysts. MarketBeat's evaluation ranked Merit Medical Systems higher than 91% of companies in the medical sector, and the company's responsibility reports have an aggregate usefulness score of 4.8 out of 5.0.

Merit Medical Systems exhibits a mixed ownership structure, with institutional investors holding the largest share at approximately 66.49%. Insiders own 2.36%, and Public Companies and Individual Investors own 31.15%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and State Street Corp.